139 related articles for article (PubMed ID: 17978485)
1. Enantioselective dehydroxylation of enterodiol and enterolactone precursors by human intestinal bacteria.
Jin JS; Zhao YF; Nakamura N; Akao T; Kakiuchi N; Min BS; Hattori M
Biol Pharm Bull; 2007 Nov; 30(11):2113-9. PubMed ID: 17978485
[TBL] [Abstract][Full Text] [Related]
2. Phylogeny of human intestinal bacteria that activate the dietary lignan secoisolariciresinol diglucoside.
Clavel T; Henderson G; Engst W; Doré J; Blaut M
FEMS Microbiol Ecol; 2006 Mar; 55(3):471-8. PubMed ID: 16466386
[TBL] [Abstract][Full Text] [Related]
3. Human intestinal bacterium, strain END-2 is responsible for demethylation as well as lactonization during plant lignan metabolism.
Jin JS; Hattori M
Biol Pharm Bull; 2010; 33(8):1443-7. PubMed ID: 20686246
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of a human intestinal bacterium, Eubacterium sp. ARC-2, capable of demethylating arctigenin, in the essential metabolic process to enterolactone.
Jin JS; Zhao YF; Nakamura N; Akao T; Kakiuchi N; Hattori M
Biol Pharm Bull; 2007 May; 30(5):904-11. PubMed ID: 17473433
[TBL] [Abstract][Full Text] [Related]
5. Further studies on a human intestinal bacterium Ruminococcus sp. END-1 for transformation of plant lignans to mammalian lignans.
Jin JS; Hattori M
J Agric Food Chem; 2009 Aug; 57(16):7537-42. PubMed ID: 19630415
[TBL] [Abstract][Full Text] [Related]
6. Human intestinal bacteria capable of transforming secoisolariciresinol diglucoside to mammalian lignans, enterodiol and enterolactone.
Wang LQ; Meselhy MR; Li Y; Qin GW; Hattori M
Chem Pharm Bull (Tokyo); 2000 Nov; 48(11):1606-10. PubMed ID: 11086885
[TBL] [Abstract][Full Text] [Related]
7. Enantioselective oxidation of enterodiol to enterolactone by human intestinal bacteria.
Jin JS; Kakiuchi N; Hattori M
Biol Pharm Bull; 2007 Nov; 30(11):2204-6. PubMed ID: 17978502
[TBL] [Abstract][Full Text] [Related]
8. Intestinal bacterial communities that produce active estrogen-like compounds enterodiol and enterolactone in humans.
Clavel T; Henderson G; Alpert CA; Philippe C; Rigottier-Gois L; Doré J; Blaut M
Appl Environ Microbiol; 2005 Oct; 71(10):6077-85. PubMed ID: 16204524
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of a human intestinal bacterium Eggerthella sp. CAT-1 capable of cleaving the C-ring of (+)-catechin and (-)-epicatechin, followed by p-dehydroxylation of the B-ring.
Jin JS; Hattori M
Biol Pharm Bull; 2012; 35(12):2252-6. PubMed ID: 23207778
[TBL] [Abstract][Full Text] [Related]
10. Clostridium saccharogumia sp. nov. and Lactonifactor longoviformis gen. nov., sp. nov., two novel human faecal bacteria involved in the conversion of the dietary phytoestrogen secoisolariciresinol diglucoside.
Clavel T; Lippman R; Gavini F; Doré J; Blaut M
Syst Appl Microbiol; 2007 Jan; 30(1):16-26. PubMed ID: 17196483
[TBL] [Abstract][Full Text] [Related]
11. Role of bifidobacteria in the activation of the lignan secoisolariciresinol diglucoside.
Roncaglia L; Amaretti A; Raimondi S; Leonardi A; Rossi M
Appl Microbiol Biotechnol; 2011 Oct; 92(1):159-68. PubMed ID: 21614502
[TBL] [Abstract][Full Text] [Related]
12. Occurrence and activity of human intestinal bacteria involved in the conversion of dietary lignans.
Clavel T; Borrmann D; Braune A; Doré J; Blaut M
Anaerobe; 2006 Jun; 12(3):140-7. PubMed ID: 16765860
[TBL] [Abstract][Full Text] [Related]
13. The treatment effects of flaxseed-derived secoisolariciresinol diglycoside and its metabolite enterolactone on benign prostatic hyperplasia involve the G protein-coupled estrogen receptor 1.
Ren GY; Chen CY; Chen WG; Huang Y; Qin LQ; Chen LH
Appl Physiol Nutr Metab; 2016 Dec; 41(12):1303-1310. PubMed ID: 27849354
[TBL] [Abstract][Full Text] [Related]
14. Bioaccessibility of lignans from flaxseed (Linum usitatissimum L.) determined by single-batch in vitro simulation of the digestive process.
Fuentealba C; Figuerola F; Estévez AM; Bastías JM; Muñoz O
J Sci Food Agric; 2014 Jul; 94(9):1729-38. PubMed ID: 24243589
[TBL] [Abstract][Full Text] [Related]
15. Production of secoisolariciresinol from defatted flaxseed by bacterial biotransformation.
Li MX; Zhu HY; Yang DH; Ma XQ; Wang CZ; Cai SQ; Liu GR; Ku BS; Liu SL
J Appl Microbiol; 2012 Dec; 113(6):1352-61. PubMed ID: 22924993
[TBL] [Abstract][Full Text] [Related]
16. Production of enterodiol from defatted flaxseeds through biotransformation by human intestinal bacteria.
Wang CZ; Ma XQ; Yang DH; Guo ZR; Liu GR; Zhao GX; Tang J; Zhang YN; Ma M; Cai SQ; Ku BS; Liu SL
BMC Microbiol; 2010 Apr; 10():115. PubMed ID: 20398397
[TBL] [Abstract][Full Text] [Related]
17. Detection of novel metabolites of flaxseed lignans in vitro and in vivo.
Quartieri A; García-Villalba R; Amaretti A; Raimondi S; Leonardi A; Rossi M; Tomàs-Barberàn F
Mol Nutr Food Res; 2016 Jul; 60(7):1590-601. PubMed ID: 26873880
[TBL] [Abstract][Full Text] [Related]
18. Bacterial conversion of secoisolariciresinol and anhydrosecoisolariciresinol.
Struijs K; Vincken JP; Gruppen H
J Appl Microbiol; 2009 Jul; 107(1):308-17. PubMed ID: 19302311
[TBL] [Abstract][Full Text] [Related]
19. Antioxidant activities of the flaxseed lignan secoisolariciresinol diglucoside, its aglycone secoisolariciresinol and the mammalian lignans enterodiol and enterolactone in vitro.
Hu C; Yuan YV; Kitts DD
Food Chem Toxicol; 2007 Nov; 45(11):2219-27. PubMed ID: 17624649
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Klebsiella sp. strain S1: a bacterial producer of secoisolariciresinol through biotransformation.
Zhou YJ; Zhu S; Yang DH; Zhao DD; Li JJ; Liu SL
Can J Microbiol; 2017 Jan; 63(1):1-10. PubMed ID: 27819481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
